Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical trial, as a predefined endpoint New peer-reviewed data published in the ...

Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...

Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical trial, as a predefined endpointNew peer-reviewed data published in the scientifi ...

Tools such as CRISPR can edit genes with precision, but the process of determining which genes to target is costly and slow, ...

A new kind of microscope is giving scientists a way to watch life inside cells with a clarity that feels almost unfair.

Buttressed by scientific developments, law is catching up with corporate and state climate inaction; a new era of accountability may follow A decade on from the adoption of the Paris Agreement, global ...

A new study has, for the first time, recorded and measured just how fast microplastics move through the gut passage of a key ...

This year’s Consumer Electronics Show (CES) is offering a glimpse into the future of healthcare. Spanning everything from ...

Opportunities in the specialty water treatment chemicals market include developing low-toxicity, eco-friendly solutions, ...

NYU Professor of Business Vasant Dhar is a pioneer in the field of artificial intelligence. He's the host of the "Brave New ...

Frameworks such as the NIST AI RMF and ISO 42001 create the foundation for effective AI governance, while quantification ...

Regentis Biomaterials (RGNT) announced publication of long-term follow-up results from its successfully concluded Phase II clinical trial of ...